Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Prosthodont ; 24(3): 194-9, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25143068

RESUMO

PURPOSE: The prevalence of Candida infections has been rising with an increasingly aging population and a larger population of immunocompromised individuals. The use of probiotics may be an alternative approach to antifungal agents in the prevention and treatment of oral candidiasis. This study aimed to evaluate the short-term effect of probiotics in reducing the infection level of oral Candida in candidiasis-asymptomatic elderly denture wearers. MATERIALS AND METHODS: In a double-blind randomized study, 59 denture wearers harboring Candida spp. in the oral cavity with no clinical symptoms were allocated into two groups: probiotic and placebo. All patients were instructed to clean the denture daily. The probiotic group poured a capsule containing lyophilized Lactobacillus rhamnosus HS111, Lactobacillus acidophillus HS101, and Bifidobacterium bifidum daily on the palatal surface of the maxillary denture, whereas the placebo group was submitted to the same regimen using placebo capsules. Candida spp. infection levels were evaluated in palate mucosa samples obtained before and after a 5-week experimental period. RESULTS: All patients harbored Candida in the palate mucosa at baseline. Fifty-five individuals completed the experimental period. The detection rate of Candida spp. was 92.0% in the placebo group after the experimental period, whereas it was reduced to 16.7% in the probiotic group. The reduction promoted by the probiotic regimen was independent of baseline characteristics such as Candida infection level and colonizing species, age of denture, and other variables. CONCLUSION: The probiotic product was effective in reducing the colonization of the oral cavity with Candida in candidiasis-asymptomatic elderly denture wearers, suggesting that this multispecies probiotic could be used to prevent oral candidiasis. CLINICAL IMPLICATIONS: Colonization of oral surfaces by Candida is considered a risk factor for invasive fungal infections. The use of a product with L. rhamnosus, L. acidophilus, and B. bifidum may represent an alternative treatment for reduction of Candida infections in elderly denture wearers.


Assuntos
Candida/efeitos dos fármacos , Candidíase Bucal/prevenção & controle , Candidíase Bucal/terapia , Dentaduras/microbiologia , Boca/microbiologia , Probióticos/uso terapêutico , Idoso , Bifidobacterium bifidum , Brasil , Desgaste de Restauração Dentária/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Lactobacillus acidophilus , Lacticaseibacillus rhamnosus , Masculino , Pessoa de Meia-Idade , Palato/microbiologia
2.
Med Mycol ; 48(1): 211-6, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20055746

RESUMO

A biofilm is a complex community of surface-associated cells enclosed in a polymer matrix. They attach to solid surfaces and their formation can be affected by growth conditions and co-infection with other pathogens. The presence of biofilm may protect the microorganisms from host defenses, as well as significantly reduce their susceptibility to antifungal agents. Pathogenic microbes can form biofilms on the inert surfaces of implanted devices such as catheters, prosthetic cardiac valves and intrauterine devices (IUDs). The present study was carried out to analyze the presence of biofilm on the surface of intrauterine devices in patients with recurrent vulvovaginal candidiasis, and to determine the susceptibility profile of the isolated yeasts to amphotericin B and fluconazole. Candida albicans was recovered from the IUDs and it was found to be susceptible to the antifungal agents when tested under planktonic growing conditions. These findings indicate the presence of the biofilm on the surface of the IUD as an important risk factor for recurrent vulvovaginal candidiasis.


Assuntos
Biofilmes/crescimento & desenvolvimento , Candida albicans/fisiologia , Candidíase Vulvovaginal/microbiologia , Dispositivos Intrauterinos/microbiologia , Adulto , Anfotericina B/farmacologia , Antifúngicos/farmacologia , Candida albicans/efeitos dos fármacos , Candida albicans/crescimento & desenvolvimento , Candida albicans/isolamento & purificação , Feminino , Fluconazol/farmacologia , Humanos , Testes de Sensibilidade Microbiana , Recidiva
3.
J Med Microbiol ; 55(Pt 12): 1693-1699, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17108273

RESUMO

A prospective study was performed to evaluate the correlation between the proposed standard of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing (AFST-EUCAST) (document 7.1) and the commercial system Etest for determining the MICs of flucytosine, amphotericin B, fluconazole, itraconazole and voriconazole for a collection of 100 clinical and environmental isolates of Cryptococcus neoformans. The agreements among Etest MICs within +/-2 log2 dilutions of AFST-EUCAST standard MICs were greater for flucytosine, fluconazole and voriconazole (76, 78 and 88 %, respectively) than for amphotericin B (5 %), the lowest agreement, and itraconazole (67 %). Overall, the correlation coefficients were statistically significant (P<0.05), and it is suggested that the Etest and AFST-EUCAST method are reliable alternatives and present good correlation for all drugs evaluated except amphotericin B. However, the observed differences related to MICs for susceptible, susceptible dose dependent and resistant strains between the methods suggest that it will be necessary to carry out further studies, including assessment of interlaboratory agreement and correlation of MICs by different methods with in vivo response.


Assuntos
Criptococose/microbiologia , Cryptococcus neoformans/efeitos dos fármacos , Testes de Sensibilidade Microbiana/métodos , Antifúngicos/farmacologia , Brasil , Humanos , Kit de Reagentes para Diagnóstico , Sensibilidade e Especificidade
4.
Mycopathologia ; 162(4): 273-80, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17039273

RESUMO

Malassezia furfur is lypophilic yeast commonly associate with dermatological disorders. In the present work, we described the isolation of 47 M. furfur strains from three groups of patients: pityriasis versicolor (21 isolates), seborrhoeic dermatitis (15 isolates) and seborrhoeic dermatitis of the HIV positive patients (11 isolates). To investigate the identity of the strains at molecular level, DNA genomic of M. furfur strains were prepared and used to RAPD-PCR analyses. RAPD assay were carried out using two decamer primers and bands pattern generated were analyzed by an Unweighted Pair-Group Method (UPGMA). Dendrogram established a distinct differentiation between M. furfur isolates from pityriasis versicolor and seborrhoeic dermatitis patients with or without AIDS. We concluded that RAPD typing presented a high discriminatory power between strains studied in this work and can be applied in epidemiological investigation of skin disease causing by M. furfur.


Assuntos
Dermatite Seborreica/microbiologia , Malassezia/genética , Técnica de Amplificação ao Acaso de DNA Polimórfico/métodos , Tinha Versicolor/microbiologia , Síndrome da Imunodeficiência Adquirida/microbiologia , DNA Fúngico/genética , Dermatite Seborreica/virologia , Genótipo , HIV , Humanos , Malassezia/isolamento & purificação , Tinha Versicolor/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA